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ALB gene causing analbuminaemia
in a Portuguese womanSir,
Homozygous or compound heterozygous variations in the
human albumin gene, ALB, (GenBank mRNA refseq:
NM_000477.6) may cause congenital analbuminaemia
(CAA; OMIM # 616000), a very rare autosomal recessive
disorder (prevalence estimated at less than 1 in 1 million),
usually characterised by the nearly total absence of albumin
(ALB) on conventional or capillary serum protein electro-
phoresis.1,2 Conversely, carriers of the disease have ALB
levels close to the lower limit of the normal range, since the
normal allele can produce about half the normal ALB
amount.1,2 CAA is generally thought of as a relatively benign
condition in adulthood. The compensatory increase of other
serum proteins, which partly can take over the lacking ALB
functions, seems to reduce the severity of symptoms. Adult
analbuminaemic individuals show few clinical signs of their
condition, such as mild oedema, hypotension, fatigue and,
mainly in adult females, a peculiar lower-body lipodystrophy
and osteoporosis, while the most common biochemical
symptoms are gross hyperlipidaemia with hyper-
cholesterolaemia, elevated LDL-cholesterol levels and
hypocalcaemia.1,2 However, the incidence of CAA and the
severity of the phenotype are probably underestimated. In
fact, ALB has a crucial role in fetal development, as well as in
the peri-natal period and childhood, so that its absence may
be life-threatening.3,4 In addition, further studies are needed
to establish whether CAA can still be regarded as a harmless
condition in adults. Normal to high ALB levels have been
reported to exert a protective effect against many pathologies,
whereas hypoalbuminaemia (ALB <35 g/L) seems related toDownloaded for Anonymous User (n/a) at R4L.Nepal from C
For personal use only. No other uses without permission. Cthe possibility of higher morbidity and mortality.5e7 In short,
ALB concentration is generally thought of as a remarkably
strong prognostic indicator of life expectancy in both sick and
seemingly healthy subjects.8 Unfortunately, the follow-up of
analbuminaemic individuals has been possible only in very
few cases so far, making it impossible to establish whether
the severe hypercholesterolaemia observed in most patients
increases the risk of atherosclerotic complications, or whether
their very low ALB level may favour the onset of other
diseases.
We describe herein the results of our investigation on an
unmarried 40-year-old woman and her mother fromMadeira
Island (Portugal). The proband presented a history of mild
mental retardation, possibly related to birth anoxia, and
post-non-Hodgkin lymphoma treatment. She only had a
slight oedema of the lower limbs following chemotherapy,
which started 5 years previously, but she did not show any
lipodystrophy or other symptoms associated with CAA. Her
ALB level was low (<15 g/L) when measured with a
standard clinical chemistry system (AU5400; Beckman
Coulter, USA), which uses a photometric bromocresol green
dye-binding method, whereas the protein was nearly absent
in serum protein capillary electrophoresis (using both SPE
and SPE Zoom buffers on the V8 device; Helena Bio-
sciences, UK) (Fig. 1). Also, a nephelometric method
(BNProSpec; Siemens Healthineers, Germany) showed the
near complete absence of ALB (Table 1). Additionally,
agarose gel electrophoresis was performed alongside normal
and pathological samples confirming the absence of albumin
(Hydragel 4 IF; Sebia, France) (Fig. 1). These data confirm
that dye-binding assays inaccurately estimate ALB levels at
low concentrations9 and that immunochemical methods
(nephelometry and turbidimetry) in association with serum
protein electrophoresis, routinely performed in clinical
chemistry laboratories, represent probably the most accurate
method to advance a well-founded suspicion of CAA on a
biochemical basis, when the possibility of more common
causes of low ALB levels can be ruled out.1,2 The total
serum protein content of the proband was close to the lower
limit of the normal range, because of the compensatory in-
crease of other serum proteins (Table 1). All the lipid
fractions were significantly increased (Table 1). The
decrease in total serum calcium reflects the corresponding
decrease in the fraction normally bound to ALB. Also, the
ionised calcium was decreased. Her renal and hepatic
functions were normal, and she showed no inflammatory
state nor gastrointestinal signs and symptoms, which ruled
out the possibility of the common causes of low ALB
concentration. The mother, who was 76 years old, showed
an ALB level of 33.9 g/L (slightly below the lower limit of
the normal range). Her electrophoretic profile revealed a
slight decrease of the ALB fraction with relative increase of
fractions a-1, a-2, b-1 and b-2. The total protein content
was normal. This behaviour is typical of heterozygous
subjects. The father was deceased at the time of our study.
The parents of the proband were first degree cousins. The
proband had three siblings, one male and two females. All of
them were tested for total protein, ALB and protein elec-
trophoresis. Total protein and ALB levels were close to the
upper limit of normality, making very unlikely the possi-
bility of a heterozygous condition. Therefore, we decided to
exclude them from the genetic study.linicalKey.com by Elsevier on November 18, 2020.
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Fig. 1 Serum protein electrophoresis of the analbuminaemic patient. (A) Capillary electrophoresis: upper part, patient; lower part, control. (B) Agarose gel electro-
phoresis: lane 1, patient; lane 2, control. The results show the almost complete absence of serum albumin, and compensatory increases in alpha-1, alpha-2, beta and
gamma fractions.
680 CORRESPONDENCE Pathology (2018), 50(6), OctoberTo confirm in our patient the diagnosis of CAA, based on
the above-mentioned clinical and biochemical findings, a
mutation analysis of the ALB was carried out following the
principles outlined in the Declaration of Helsinki. After we
obtained informed consent, genomic DNA was extracted
from whole blood of the proband, her mother, and two un-
related healthy volunteers as a control. Fourteen genomicTable 1 Clinical laboratory values of the analbuminaemic patient
Analyte Result Units Reference
interval
Serum albumin (nephelometric) <0.341 g/L 35e52
Serum albumin (colorimetric) <15 g/L 35e48
Urine albumin <0.07 g/L <0.2
Serum total protein 58.4 g/L 60e80
Urine total protein 0.05 g/L <0.1
Albumina 2.8 g/L 38e49
Alpha-1-globulinsa 7.3 g/L 1.8e3.5
Alpha-2-globulinsa 13.7 g/L 3.4e7.4
Beta-1-globulinsa 9.0 g/L 3.8e6.4
Beta-2-globulinsa 4.8 g/L 1.7e5.0
Gamma-globulinsa 20.8 g/L 6.8e15
Ratio albumin/globulins 0.05 ratio 0.99e1.81
IgA 2.82 g/L 0.7e4.0
IgG 17.5 g/L 7e16
IgM 1.81 g/L 0.4e2.3
IgE 710 mg/L <288
IgG1 12.6 g/L 4.05e10.11
IgG2 4.44 g/L 1.69e7.86
IgG3 1.2 g/L 0.11e0.85
IgG4 0.397 g/L 0.03e2.01
Transferrin 4.226 g/L 2.0e3.6
Alpha-1-antitrypsin 3.19 g/L 0.9e2.0
Caeruloplasmin 0.512 g/L 0.22e0.58
Haptoglobulin 0.97 g/L 0.3e2.0
C3 2.01 g/L 0.9e1.8
C4 0.399 g/L 0.1e0.4
Total cholesterol 11.86 mmol/L <5.18
HDL cholesterol 4.7 mmol/L 1.03e1.55
LDL cholesterol 6.6 mmol/L <4.14
Triglycerides 2.38 mmol/L <1.8
Serum calcium 1.92 mmol/L 2.23e2.58
Serum ionised calcium 0.76 mmol/L 1.16e1.32
Results falling outside the reference interval are in bold.
a Determined by capillary electrophoresis.
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their intron-exon junctions, were polymerase chain reaction
(PCR) amplified using specific primer pairs as described by
Watkins et al.,3 and then studied by heteroduplex and single-
strand conformational polymorphism analysis. However, in
this case this strategy did not allow an unambiguous identi-
fication of the mutation site and therefore all the fragments
were submitted to direct DNA sequencing. This revealed that
the only molecular defect was located in the 356 bp long
region amplified by using PCR primers A05A and A06A
encompassing exon 3 and its intron-exon junctions.3,10 The
patient was homozygous for a A>G transition at nucleotide
c.138-2, the second last base of intron 2, and the mother was
heterozygous for the wild type and mutated alleles, as the
sequencing electropherograms showed the presence of two
superimposed peaks at that position, representing the normal
(A) and the variant (G) base (Fig. 2). These results,
confirming the inheritance of the trait, allowed the identifi-
cation of a novel c.138-2 A>G variant, for which we suggest
the name Madeira, as the cause of CAA in our patient. The
c.138-2 A>G variant is described as ‘likely pathogenic’ ac-
cording to ACMG guidelines. In fact, it is located within 2
of canonical splice site (rule PVS1) and the allele was not
found in GnomAD and ExAC Exome Aggregation Con-
sortium databases (rule PM2).10 All 14 junctions present in
the ALB conform with the GT and AG consensus sequences
present at the 5ʹ and 3ʹ splice sites, respectively.11 The
Madeira variant destroys the invariant AG dinucleotide
sequence at the acceptor splice site of intron 2, and it is well
known that intronic alterations located in consensus splicing
regions lead to aberrant transcript(s), either lacking one or
more exons, or even part of them, or retaining intronic se-
quences.12 We could not establish the effects of this splicing
mutation at the mRNA and, consequently, at the protein level,
but no evidence has been so far reported for the presence of
aberrant truncated ALB variants in the serum of analbumi-
naemic individuals.1,2
The Madeira variant is the 25th different defect identified
as a cause of CAA among the 47 cases so far characterised at
the molecular level: ten mutations affecting splicing, seven
nonsense mutations, six frame-shift/deletions, one frame-linicalKey.com by Elsevier on November 18, 2020.
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Fig. 2 Genomic DNA sequence electropherograms of the members of the Portuguese family. The region encompassing exon 3 and the intron2eexon3 and exon3e
intron3 junctions was amplified using PCR primers A05A and A06A and then submitted to direct DNA sequencing. The arrow indicates the A>G transition at nucleotide
c.138-2, the second last base of intron 2. The patient is homozygous for this mutation and the mother heterozygous for the wild type and mutated alleles, as seen by the
presence of two superimposed peaks.
CORRESPONDENCE 681shift/insertion and one mutation in the start codon.2,13 Of the
molecular defects affecting splicing, the Madeira variant is
the second identified at an acceptor splice site, whereas five
are at donor splice sites, suggesting that the latter are more
prone to mutations.2 The finding that the CAA causing var-
iants are located in nine different exons and in seven different
introns indicates that CAA is the result of widely scattered
and randomly occurring different molecular defects. Whereas
the Madeira variant, as most of the other causative defects, is
so far unique, two mutations have been identified in appar-
ently unrelated and geographically distant families: the two
base deletion c.228_229delAT (analbuminaemia Kayseri),
which is by far the most frequent cause of the trait, ac-
counting for 13 of the cases characterised at the molecular
level, and the splicing defect c.1289þ1G>A of analbumi-
naemia Guimarães, identified in four cases.2,13 These defects
seem to be located in mutational hot spots of the ALB. The
cumulative frequency of the CAA causing variants reported
in the large population sequencing project, ExAC, is 8.3 in
100,000. It is worth noting that Kayseri has the highest allele
frequency at the heterozygous state in the average normal
population (5.8 in 100,000).10 In contrast, the cumulative
frequency of the ALB variants known to cause alloalbu-
minaemia, a benign condition characterised by the pres-
ence of a circulating variant of ALB, is significantly
higher: 2.17 in 1000.10 The very low frequency of the
CAA causing variants supports the hypothesis that the lack
of ALB may be lethal during the fetal life or in the peri-
natal period.Downloaded for Anonymous User (n/a) at R4L.Nepal from C
For personal use only. No other uses without permission. CThe data here reported allowed us to identify the 25th
different variant, a c.138-2 A>G defect in intron 2, as the
cause of CAA in our patient. The results expand the mutation
spectrum of ALB underlying this condition and contribute to
shed light on the patho-physiology and on the molecular
genetics of CAA.
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squamous cell carcinoma
presenting as a metastasis to the
thyroid masquerading as a primary
malignancy, diagnosed by cytologySir,
Intra-thyroid metastasis (ITM) is uncommon despite the
thyroid gland being a highly vascular organ, second only to
adrenal glands in relative vascular perfusion. The overall
incidence of ITM ranges from 0.6% to 5.7% with metastatic
squamous cell carcinoma (SCC) an even rarer entity.1 Au-
topsy series report higher rates, ranging from 1.25% to 24%
but most of these cases are not detected clinically.2,3
The oncogenic role of human papillomaviruses (HPV) in
cervical cancer is well known but despite multiple meta-
analyses their effect on esophageal SCC remains controver-
sial. There are significant worldwide geographical differences
in the overall incidence of HPV related oesophageal SCC,
varying from 11.7% to 38.9%, and Australia is categorised as
a low risk country having reported rates of 2.5 per 100,000.4
Herein we present the first case of metastatic HPV positive
SCC of the thyroid originating in the oesophagus of a young
male.
A 44-year-old man presented with 6 week history of
worsening odynophagia and dysphagia. A computed to-
mography scan of the head and neck showed trachea
compression by a 50 mm mass from the lower pole of the left
thyroid gland without localised lymphadenopathy. A primary
thyroid malignancy was suspected and urgent surgery was
planned. An ultrasound guided fine needle aspiration (FNA)
was performed and five air-dried smears and a cell block were
received. Smears revealed malignant epithelial cells, some
spindly, occurring singly and in clusters, showing dense
cytoplasm suggestive of squamous differentiation (Fig. 1A).
Immunohistochemistry (IHC) performed on a cell blockDownloaded for Anonymous User (n/a) at R4L.Nepal from C
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confirming the squamous nature (Fig. 1B).
The possibilities considered were primary thyroid SCC,
anaplastic thyroid carcinoma with a squamous component or
metastatic SCC. Given the age of the patient and rarity of
primary anaplastic and squamous cell carcinoma, the likeli-
hood of metastasis needed exclusion. These findings were
discussed with the clinical team and immediate surgery was
postponed until further investigation.
Polymerase chain reaction (PCR) HPV DNA testing was
performed as the topographic site is in close proximity to the
oropharynx that is commonly known to be associated with
high risk HPV infections and primary thyroid carcinomas
have never been shown to be associated with HPV infection.
The results were positive for high risk HPV-16 genotype and
the finding was highly suggestive of metastatic SCC of the
head and neck region.
The patient proceeded to have an urgent oesophagoscopy
that showed a 40 mm exophytic upper oesophageal tumour at
15e20 cm. Histology of the mass biopsy showed a similar
morphology (Fig. 2A), immunophenotype, and HPV-16 ge-
notype (Fig. 2B) to the thyroid deposit, confirming the
diagnosis of a primary moderately differentiated oesophageal
SCC with metastases to thyroid. Staging imaging demon-
strated no other distant metastases.
The patient was referred to the otolaryngology multidisci-
plinary team (MDT) and was commenced on chemo-
radiotherapy. The management was complicated by tracheal
stenosis and a stent was inserted. Follow up positron emission
tomography scan showed complete metabolic response of both
the upper oesophageal mass and the ITM. Subsequent bron-
chial brushings, tracheal/bronchial washings, subglottic and
lower trachea biopsies were all negative for malignancy. The
patient remains under close surveillance and further follow up
18 months post-diagnosis revealed no disease recurrence.
ITM is relatively uncommon and can often masquerade as
a primary thyroid neoplasm. The distinction is significant as
they have different management pathways. The potential
long latency period for the appearance of metastases makes it
seem unrelated to the primary malignancy many years pre-
viously, representing a diagnostic pitfall for the unsuspecting
pathologist.
ITM can originate from any organ system with commonly
reported sites including lung, kidney, breast, skin and
oesophagus. In cases with poorly differentiated disease the
site of origin may not be identifiable. Autopsy series have
reported lung to be the most common primary origin of ITM,
whereas clinical series have shown renal cell carcinoma to be
more common.5 It is thought that this difference may be
attributed to the variable clinical presentation, nature of dis-
ease and differing management guidelines.3,5
The appearance of ITM can be the first presentation of
metastases or can occur simultaneously with other metasta-
ses. The lag time between the diagnosis of a primary malig-
nancy and the appearance of ITM can be years (range 1
monthe26 years) and often signifies poor prognosis with an
average survival of 12 months.3,6e8 The short survival time
may reflect the advanced stage of disease progression at
diagnosis or could be due to the aggressive nature of disease.
Oesophageal carcinoma with ITM often represents a pre-
terminal event.3
Cases with ITM are commonly identified via three
different scenarios: (1) patients can present with thyroidlinicalKey.com by Elsevier on November 18, 2020.
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